Literature DB >> 21848804

Induction of a stress response in Lactococcus lactis is associated with a resistance to ribosomally active antibiotics.

James M Dorrian1, Deborah A Briggs, Michael L Ridley, Robert Layfield, Ian D Kerr.   

Abstract

The acquisition of multidrug resistance in bacteria underlies the failure of antimicrobial therapy, and the emergence of pathogens that are resistant to almost the entire armoury of antibiotics. Among the proteins that can mediate or contribute to the drug-resistance profile in Gram-positive bacteria is a subset of ATP-binding cassette proteins that are comprised of a tandem-repeated nucleotide-binding domain. In this study, we expressed one of these NBD(2) proteins, LmrC, in an antibiotic-sensitive Gram-positive host strain (Lactococcus lactis) and demonstrated the acquisition of resistance to ribosomally active antibiotics. Mutation of key catalytic residues suggested that the resistance profile was the result of a cellular response, rather than being a function of the NBD(2) protein itself. This observation was confirmed by 2D SDS/PAGE, which demonstrated that the expression of the NBD(2) protein induced a stress response in L. lactis. A model combining this stress response induction and the acquisition of antibiotic resistance is proposed.
© 2011 The Authors Journal compilation © 2011 FEBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21848804     DOI: 10.1111/j.1742-4658.2011.08305.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  2 in total

Review 1.  Ribosome protection by ABC-F proteins-Molecular mechanism and potential drug design.

Authors:  Rya Ero; Veerendra Kumar; Weixin Su; Yong-Gui Gao
Journal:  Protein Sci       Date:  2019-03-04       Impact factor: 6.725

2.  Ribosome Protection as a Mechanism of Lincosamide Resistance in Mycobacterium abscessus.

Authors:  Kelley R Hurst-Hess; Paulami Rudra; Pallavi Ghosh
Journal:  Antimicrob Agents Chemother       Date:  2021-08-30       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.